Clinical Trial Update: Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immunogenicity and safety of fractional doses of Yellow Fever vaccines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Yellow Fever

Drugs mentioned

• YEFE

Snippet

Sponsor: Epicentre | Conditions: Yellow Fever | Phase 4 | Status: COMPLETED